Saturday, September 26, 2009
Sunday, December 07, 2008
經濟風暴中亞洲的功能食品市場機會潛力仍大
作者 Kevin Hu , Wedar Biotechnology
這一波經濟風暴太大了, 雖然10幾年來見識過不少次的經濟風暴, 但都沒有這一回來的兇猛 , 以前都是地區性的, 短期性的, 偶發性的, 這一回是全球性特別是美國都倒下去的情況, 必須非常小心以待, 以前碰過健保風暴, 97年的亞洲金融風暴, 2001 年的網路泡沫與美國崩盤, 2003 年的SARS `...... 都沒有這一回來得嚴重
不過到底有多嚴重, 目前我們還看不到底, 電子業已經趴下去了, 保健營養業到底會受到什麼影響?
1990年代以來, 日本發生非常嚴重的經濟風暴, 各行各業都成長緩慢甚至於是負成長, 不過, 過去 18年來, 日本市場的保健業, 仍然以非常快速的成長, 甚至一度是 好幾年都 2 位數成長. 這歷史現象顯示, 先進國家受到經濟風暴, 民眾花在自我保健的費用其實並不會縮減, 不過, 在台灣到底如何, 因為缺乏數據, 我目前不敢定論. 經驗上, 过去每回遇到經濟風暴, 很多體質不佳的公司會倒閉, 大家信心都會變得很低落, 不過, 這剛好也是產業重新洗牌的時間, 在不景氣的年代, 剛好是許多長青企業進行品牌投資和產品重整的機會點
對岸的中國大陸, 雖然相對受到經濟風暴的傷害較小, 但別忘了先前還沒有發生風暴時對岸也剛好是調整經濟政策, 由外銷轉內銷的重大轉變, 沿海許多的外銷為主的企業受到人民弊升值, 去年的勞動法, 退稅與稅制調整... 等一連串的 調整, 剛好碰上了這回的全球風暴, 對內地市場的影響不可不大, 雖然挾帶著全球最高最快速成長的 近三億新興中產階級社會興起的機會, 保健業應該有很好的成長機會, 不過, 自 2004年以來到現在, 中國的食品與藥品行業出現狀況不斷, 行政與管理系統一直不穩定, 相對整體市場的信心因為政策搖擺不定, 一直沒有非常突破的成長, 可說是行業的暗淡期, 加上最近毒奶事件, 可說是已經對於中國的官僚系統之管理制度與能力又加上一個重擊, 一方面可說也是個機會, 如果能夠由SFDA 的改革上面開始, 進行中國大規模的食品與藥品行業的改革, 搭接上全球數量最龐大的消費者族群與最具潛力的市場, 應該 是可以見到這行業的春天, 目前我個人認為影響市場最大的因素不是 消費者受到經濟風暴的問題, 而是信心與市場管理機制未明導致企業投入信心不足的問題
下面有一篇文章提到亞洲市場在經濟風暴中, 仍然是以日本與中國最具有成長潛力
http://www.naturalproductsinsider.com/hotnews/nutraceutical-opportunities-china-japan.html
, 個人覺得有趣的是, 保健市場的興旺, 其實與經濟風暴沒有很大的關連, 這是過去歷史的法則, 因為個人在投資自己健康的方面並非屬於衝動消費, 是屬於相對 理性的消費行為, 在經濟受到影響的情況下, 被砍掉的家庭預算通常會是在衝動與非必要消費, 比方消費電子等, 但保健支出不會受到這樣的影響
在保健消費方面, 整體成長受到主要的因素自人口結構, 國家藥政管理制度這兩個宏觀的影響很大, 中國與日本對於保健的市場管理機制都相對比較嚴格, 但人口結構上, 日本是老人社會, 中國則是相對較年輕的人口結構, 中產階級高速成長, 因此, 雖然市人口結構不同, 對於需求產品有所區隔, 但宏觀上面, 挾龐大的人口數量, 中國與日本的保健市場仍是亞洲最龐大且具潛力的. 以日本來說, 銀髮族消費將占有高的比例, 中國則以青年女性的保健消費為主, 美容 與基本日常營養方面市場需求將更擴大
最後轉載該篇全文供各位有興趣研究者研究, 我個人長期在台灣與中國市場經營保健行業, 基本上感覺該文之分析十分中肯
Nutraceutical Opportunities in China, Japan
12/05/2008
LONDON—Japan is known for its innovation in the functional food and beverage field, while China offers the world’s largest economic potential. With slowing economic growth in Western nations, attention is turning to Asia to develop markets for nutraceutical and functional food products. A new report from Business Insights, available through Research & Markets, explores the current regulations, consumer behavior and market trends in China and Japan.
Among the good news:
The Asian functional food and beverage market and is set to increase at a CAGR of 5.6 percent from $36.6 billion in 2007 to $48 billion by 2012. Japan and China are leaders in category, with growth for each country set to continue at a CAGR of 5.3 percent and 5.9 percent respectively.
Between 2005 and 2008, beauty foods increased from a share of 2.3 percent of all functional products launched in 2005 in China, to 5.2 percent in 2008. The beauty segment as it relates to functional ingredients and foods is an extension of the Japanese model of using innovative ingredient combinations.
In 2007 the total food and drinks market in China and Japan was $209.9 billion and $253.5 billion, respectively. By 2011, China is expected to grow to $292.7 billion in food and beverage sales, making it by far the largest market in Asia.
In China, there are 27 categories of product-specific health claims defined as either nutrient function claims or reduction of disease claims. According to the State Food and Drugs Administration (SFDA), only 27 to 33 percent of all products submitted between 2003 and 2005 were authorized, with only 30 percent of those approved making it onto the market.
Additional topics addressed include the use of labels and logos in the Japanese market, the Chinese regulatory system, food safety issues and demographic trends.
Sources:
MarketWatch: Research and Markets: Nutraceuticals in China and Japan Report: Emerging Opportunities and Their Crossover Potential for Western Markets
另外關於中國的食品管理最近的變化, 可參考此篇
http://www.naturalproductsinsider.com/articles/regulations-china-natural-products.html
這一波經濟風暴太大了, 雖然10幾年來見識過不少次的經濟風暴, 但都沒有這一回來的兇猛 , 以前都是地區性的, 短期性的, 偶發性的, 這一回是全球性特別是美國都倒下去的情況, 必須非常小心以待, 以前碰過健保風暴, 97年的亞洲金融風暴, 2001 年的網路泡沫與美國崩盤, 2003 年的SARS `...... 都沒有這一回來得嚴重
不過到底有多嚴重, 目前我們還看不到底, 電子業已經趴下去了, 保健營養業到底會受到什麼影響?
1990年代以來, 日本發生非常嚴重的經濟風暴, 各行各業都成長緩慢甚至於是負成長, 不過, 過去 18年來, 日本市場的保健業, 仍然以非常快速的成長, 甚至一度是 好幾年都 2 位數成長. 這歷史現象顯示, 先進國家受到經濟風暴, 民眾花在自我保健的費用其實並不會縮減, 不過, 在台灣到底如何, 因為缺乏數據, 我目前不敢定論. 經驗上, 过去每回遇到經濟風暴, 很多體質不佳的公司會倒閉, 大家信心都會變得很低落, 不過, 這剛好也是產業重新洗牌的時間, 在不景氣的年代, 剛好是許多長青企業進行品牌投資和產品重整的機會點
對岸的中國大陸, 雖然相對受到經濟風暴的傷害較小, 但別忘了先前還沒有發生風暴時對岸也剛好是調整經濟政策, 由外銷轉內銷的重大轉變, 沿海許多的外銷為主的企業受到人民弊升值, 去年的勞動法, 退稅與稅制調整... 等一連串的 調整, 剛好碰上了這回的全球風暴, 對內地市場的影響不可不大, 雖然挾帶著全球最高最快速成長的 近三億新興中產階級社會興起的機會, 保健業應該有很好的成長機會, 不過, 自 2004年以來到現在, 中國的食品與藥品行業出現狀況不斷, 行政與管理系統一直不穩定, 相對整體市場的信心因為政策搖擺不定, 一直沒有非常突破的成長, 可說是行業的暗淡期, 加上最近毒奶事件, 可說是已經對於中國的官僚系統之管理制度與能力又加上一個重擊, 一方面可說也是個機會, 如果能夠由SFDA 的改革上面開始, 進行中國大規模的食品與藥品行業的改革, 搭接上全球數量最龐大的消費者族群與最具潛力的市場, 應該 是可以見到這行業的春天, 目前我個人認為影響市場最大的因素不是 消費者受到經濟風暴的問題, 而是信心與市場管理機制未明導致企業投入信心不足的問題
下面有一篇文章提到亞洲市場在經濟風暴中, 仍然是以日本與中國最具有成長潛力
http://www.naturalproductsinsider.com/hotnews/nutraceutical-opportunities-china-japan.html
, 個人覺得有趣的是, 保健市場的興旺, 其實與經濟風暴沒有很大的關連, 這是過去歷史的法則, 因為個人在投資自己健康的方面並非屬於衝動消費, 是屬於相對 理性的消費行為, 在經濟受到影響的情況下, 被砍掉的家庭預算通常會是在衝動與非必要消費, 比方消費電子等, 但保健支出不會受到這樣的影響
在保健消費方面, 整體成長受到主要的因素自人口結構, 國家藥政管理制度這兩個宏觀的影響很大, 中國與日本對於保健的市場管理機制都相對比較嚴格, 但人口結構上, 日本是老人社會, 中國則是相對較年輕的人口結構, 中產階級高速成長, 因此, 雖然市人口結構不同, 對於需求產品有所區隔, 但宏觀上面, 挾龐大的人口數量, 中國與日本的保健市場仍是亞洲最龐大且具潛力的. 以日本來說, 銀髮族消費將占有高的比例, 中國則以青年女性的保健消費為主, 美容 與基本日常營養方面市場需求將更擴大
最後轉載該篇全文供各位有興趣研究者研究, 我個人長期在台灣與中國市場經營保健行業, 基本上感覺該文之分析十分中肯
Nutraceutical Opportunities in China, Japan
12/05/2008
LONDON—Japan is known for its innovation in the functional food and beverage field, while China offers the world’s largest economic potential. With slowing economic growth in Western nations, attention is turning to Asia to develop markets for nutraceutical and functional food products. A new report from Business Insights, available through Research & Markets, explores the current regulations, consumer behavior and market trends in China and Japan.
Among the good news:
The Asian functional food and beverage market and is set to increase at a CAGR of 5.6 percent from $36.6 billion in 2007 to $48 billion by 2012. Japan and China are leaders in category, with growth for each country set to continue at a CAGR of 5.3 percent and 5.9 percent respectively.
Between 2005 and 2008, beauty foods increased from a share of 2.3 percent of all functional products launched in 2005 in China, to 5.2 percent in 2008. The beauty segment as it relates to functional ingredients and foods is an extension of the Japanese model of using innovative ingredient combinations.
In 2007 the total food and drinks market in China and Japan was $209.9 billion and $253.5 billion, respectively. By 2011, China is expected to grow to $292.7 billion in food and beverage sales, making it by far the largest market in Asia.
In China, there are 27 categories of product-specific health claims defined as either nutrient function claims or reduction of disease claims. According to the State Food and Drugs Administration (SFDA), only 27 to 33 percent of all products submitted between 2003 and 2005 were authorized, with only 30 percent of those approved making it onto the market.
Additional topics addressed include the use of labels and logos in the Japanese market, the Chinese regulatory system, food safety issues and demographic trends.
Sources:
MarketWatch: Research and Markets: Nutraceuticals in China and Japan Report: Emerging Opportunities and Their Crossover Potential for Western Markets
另外關於中國的食品管理最近的變化, 可參考此篇
http://www.naturalproductsinsider.com/articles/regulations-china-natural-products.html
Sunday, August 24, 2008
Friday, April 04, 2008
WEDAR exhibit novel ingredient in FIC 2008
查看文章→【WEDAR exhibit novel ingredient in FIC 2008】
WEDAR Nutraosurce Group bring novel enzyme and scientific proven botanical extract to the chinese market in the largest food ingredient and additive tradeshow in shanghai last week .
Just annouced as strategic partnership relationship with brand ingredient supplier last year , including nationatioal enzyme company (http://www.nationalenzymes.com) , Fytexia (http://www.fytexia.com ) . Wedar is set to enter to one of the largest potential functional ingredient market in the world . Wedar exhibit in FIC and introduce several novel ingredients to the industrial customers in chinese market.
Branch office located in Shanghai since 2003 , Wedar is now a multinational brand ingredient supplier to the chinese market , including Taiwan , China , HongKong , and some chinese market in Malaysia , Singapore and Indonesia. Wedar start up the business since 1998 , by professional team leaded by Kevin Hu , who is also a biochemist , focus on the high end functional ingredient with scientific evidence in the global supply side .
" Wedar is very professional at local service to the industrial customers ", said Kevin Hu, President of Wedar Nutrasource Group. " . Years of expertise and experience in nutraceutical industry , from vendor network , to value chain strategically allianced with brand ingredient vendors , Wedar is very aware of the local business environment .
The major difficulty of chinese market come from strict regulation and people's low awareness of quality , Wedar focus on major key customers in the market , bring brand value to the local market through the introduction of scientific evidence and total solution serivce , from import / export , regulation, production , registration and education to cusotmers.
" We believe only very few companies as a expertise in this industry will survive in the growing bigger chinese market " said Kevin Hu . " The price competition is killing many companies , but as chinese consumers are getting richer , people's awareness and tighten regulation will be a high barrier to foreign companies who is willing to enter chinese market " , Wedar is now becoming consolidated business partner of brand supplier in US and EU .
Wedar is now also just established a in house ,bio-active ingredient screeen platform , from LC-GC/MS Mass spectrophotometer , to untra- high sensitive bioavailability in vivo assay system , as well as the Nutrigenomic assay platform. The system is under stringent repeated testing now . Wedar will announce the bio-active assay system and start to investigate several bioactive novel ingredient to publication. The new assay system will bring more scientifc value to the ingredient , and will be a effective tool in screening of novel ingredient s from china . China is one of the largest natural material exporter in the global market , most of them are price competition , and lack of scientific evidence. Wedar will be one of the very few companies capable of investigating natural ingredient from chemical assay to nutrigenomic study.
Wedar is also collaborating with several international vendors from europe , japan , New Zealand and US companies , to test the existing ingredient using the novel bioassay system , and bring more published science to the product to add brand value to the market.
The next tradeshow for WEDAR will be CPHI Shanghai 2008
WEDAR Nutraosurce Group bring novel enzyme and scientific proven botanical extract to the chinese market in the largest food ingredient and additive tradeshow in shanghai last week .
Just annouced as strategic partnership relationship with brand ingredient supplier last year , including nationatioal enzyme company (http://www.nationalenzymes.com) , Fytexia (http://www.fytexia.com ) . Wedar is set to enter to one of the largest potential functional ingredient market in the world . Wedar exhibit in FIC and introduce several novel ingredients to the industrial customers in chinese market.
Branch office located in Shanghai since 2003 , Wedar is now a multinational brand ingredient supplier to the chinese market , including Taiwan , China , HongKong , and some chinese market in Malaysia , Singapore and Indonesia. Wedar start up the business since 1998 , by professional team leaded by Kevin Hu , who is also a biochemist , focus on the high end functional ingredient with scientific evidence in the global supply side .
" Wedar is very professional at local service to the industrial customers ", said Kevin Hu, President of Wedar Nutrasource Group. " . Years of expertise and experience in nutraceutical industry , from vendor network , to value chain strategically allianced with brand ingredient vendors , Wedar is very aware of the local business environment .
The major difficulty of chinese market come from strict regulation and people's low awareness of quality , Wedar focus on major key customers in the market , bring brand value to the local market through the introduction of scientific evidence and total solution serivce , from import / export , regulation, production , registration and education to cusotmers.
" We believe only very few companies as a expertise in this industry will survive in the growing bigger chinese market " said Kevin Hu . " The price competition is killing many companies , but as chinese consumers are getting richer , people's awareness and tighten regulation will be a high barrier to foreign companies who is willing to enter chinese market " , Wedar is now becoming consolidated business partner of brand supplier in US and EU .
Wedar is now also just established a in house ,bio-active ingredient screeen platform , from LC-GC/MS Mass spectrophotometer , to untra- high sensitive bioavailability in vivo assay system , as well as the Nutrigenomic assay platform. The system is under stringent repeated testing now . Wedar will announce the bio-active assay system and start to investigate several bioactive novel ingredient to publication. The new assay system will bring more scientifc value to the ingredient , and will be a effective tool in screening of novel ingredient s from china . China is one of the largest natural material exporter in the global market , most of them are price competition , and lack of scientific evidence. Wedar will be one of the very few companies capable of investigating natural ingredient from chemical assay to nutrigenomic study.
Wedar is also collaborating with several international vendors from europe , japan , New Zealand and US companies , to test the existing ingredient using the novel bioassay system , and bring more published science to the product to add brand value to the market.
The next tradeshow for WEDAR will be CPHI Shanghai 2008
Sunday, February 17, 2008
2008台灣美容化妝品展 , 薇達多酚館展出多種新產品
薇達股份有限公司為專業保健品開發公司，提供目前市面上最齊全的多酚相關商品，如藍莓多酚、蔓越莓多酚、青花椰菜多酚…等，成立薇達多酚館購物網站，並積極開展實體通路。薇達營養品系列產品齊全，功能訴求完整，並堅持採用歐美大廠經科學驗證的品牌原料，更將天然營養素材帶入保養品及個人清潔用品，引起消費者的關注。
薇達系列保養品，訴求天然植物多酚，此次美容展薇達仍以最具特色的蔓越莓多酚系列商品做為主打，包括了身體及臉部的清潔及保養，專為忙碌的都會女性量身打造，希望女性朋友們再忙也要留點時間呵護自己。該系列採用的蔓越莓籽油，是從蔓越莓籽冷壓萃取而來，不含有機溶濟，天然而珍貴。蔓越莓籽油含有最高活性的維生素E(tocotrienols)，具有極佳的親膚性及滋潤效果，非常適合添加在肌膚保養保濕產品、化妝品、甚至是寶寶的皮膚護理產品中。蔓越莓籽油在歐美化妝保養品市場接受度不斷成長，主要效能發揮在減少肌膚小細紋及解決冬日肌膚乾燥問題 。
為慶祝2月份美容展，薇達將於展會現場舉辦多項購惠活動，包括全系列商品超值折扣，持薇達會員卡優惠再享95折、精選保養品及保健品超低價加購，當然也會推出薇達展會中最讓忠實顧客期待的蔓越莓多酚牙膏組合優惠活動，以上活動均是一年一度，專屬於展會的促銷活動，歡迎蒞臨參觀選購
薇達多酚館網址：www.wedocare.com.tw免付費諮詢電話：0800-555-528 產品服務專線：07-55205272008美容化妝品展：2/28~3/3 世貿三館 739&741
薇達系列保養品，訴求天然植物多酚，此次美容展薇達仍以最具特色的蔓越莓多酚系列商品做為主打，包括了身體及臉部的清潔及保養，專為忙碌的都會女性量身打造，希望女性朋友們再忙也要留點時間呵護自己。該系列採用的蔓越莓籽油，是從蔓越莓籽冷壓萃取而來，不含有機溶濟，天然而珍貴。蔓越莓籽油含有最高活性的維生素E(tocotrienols)，具有極佳的親膚性及滋潤效果，非常適合添加在肌膚保養保濕產品、化妝品、甚至是寶寶的皮膚護理產品中。蔓越莓籽油在歐美化妝保養品市場接受度不斷成長，主要效能發揮在減少肌膚小細紋及解決冬日肌膚乾燥問題 。
為慶祝2月份美容展，薇達將於展會現場舉辦多項購惠活動，包括全系列商品超值折扣，持薇達會員卡優惠再享95折、精選保養品及保健品超低價加購，當然也會推出薇達展會中最讓忠實顧客期待的蔓越莓多酚牙膏組合優惠活動，以上活動均是一年一度，專屬於展會的促銷活動，歡迎蒞臨參觀選購
薇達多酚館網址：www.wedocare.com.tw免付費諮詢電話：0800-555-528 產品服務專線：07-55205272008美容化妝品展：2/28~3/3 世貿三館 739&741
WEDAR崴達歡迎各界參觀FIC 2008 (Food Ingredients China)
由中國食品添加劑和配料協會和中國貿促會輕工行業分會共同主辦的第十二屆中國國際食品添加劑和配料展覽會暨第十八屆全國食品添加劑生產應用技術展示會FIC（Food Ingredients China 2008），FIC已經成為中國及亞洲食品添加劑和配料行業規模最大的、最具權威性的行業國際品牌展覽會，將於 2008 年 3 月 26 － 28 日舉行，在上海光大會展中心、上海國際展覽中心和上海世貿商城三館同時隆重舉行，崴達今年除了 FIC 之外, 也將參加六月份上海舉辦的 CPHI
FIC 2008 展將在上海光大會展中心、上海國際展覽中心和上海世貿商城同時展出，比上屆新增加一個展館，再次擴大了展出規模，總展出面積達 52000 多平方米，擴展了參展企業的宣傳空間。FIC2008 超大規模的展出面積，為參展商搭建了更寬廣的展示交易平臺，為企業和行業的發展帶來更大的發展商機。
此次參展來自 30 個國家和地區的 1000 多家公司報名參展，國際參展商近 200 家，其中包括比利時、日本、愛爾蘭國家展團、德國.....等來自全球各地的公司。
2008年第十二屆中國國際食品添加劑與配料展會 FIC崴達展位號：東館1樓，DB77展館位置：光大會展中心，國際展區及綜合館，上海市徐匯區漕寶路 78 號期盼各界先進屆時能親臨會場指導參觀。
台灣地區客戶連絡Mandy Wu mandy@wedar.com 大陸地區連絡 Lucia Hu lucia@wedar.com 021-54900271
FIC 2008 展將在上海光大會展中心、上海國際展覽中心和上海世貿商城同時展出，比上屆新增加一個展館，再次擴大了展出規模，總展出面積達 52000 多平方米，擴展了參展企業的宣傳空間。FIC2008 超大規模的展出面積，為參展商搭建了更寬廣的展示交易平臺，為企業和行業的發展帶來更大的發展商機。
此次參展來自 30 個國家和地區的 1000 多家公司報名參展，國際參展商近 200 家，其中包括比利時、日本、愛爾蘭國家展團、德國.....等來自全球各地的公司。
2008年第十二屆中國國際食品添加劑與配料展會 FIC崴達展位號：東館1樓，DB77展館位置：光大會展中心，國際展區及綜合館，上海市徐匯區漕寶路 78 號期盼各界先進屆時能親臨會場指導參觀。
台灣地區客戶連絡Mandy Wu mandy@wedar.com 大陸地區連絡 Lucia Hu lucia@wedar.com 021-54900271
Tuesday, September 04, 2007
查看文章→【Wedar agreement with Misling for Lectranal 】
查看文章→【Wedar agreement with Misling for Lectranal 】
Wedar nutrasouce Inc. A leading branded name nutraceutical ingredient supplier to the asia pacific and chinese market , has already signed a exclusive agreement with a nutraceutical innovator in croatia , named Milsing , to introduce the novel patented allergy relief branded ingredient LECTRANAL , to both china and taiwan market.
Lectranal® is a new allergy relief ingredient.
Lectranal® provides an innovative solution for relieving the following allergic reactions:
- allergic rhinitis
- allergic conjunctivitis
- allergic asthma
- atopic dermatitis
Lectranal® is composed of a herbal and a mineral compound produced by using a patent-pending procedure. For hundreds of years, Astragalus membranaceus, a perennial plant, has been used in traditional Chinese medicine for the relief of indigestion, as well as to strengthen the immune system.
Our scientists target compounds in the roots of Astragalus membranaceus that help relieve allergic reactions. Since we believe that these substances cannot be absorbed in their active form when taken orally, we have developed a new herbal and mineral complex that will enable their oral absorption.
A combination of that specific extract and a mineral carrier is obtained through a patent-pending procedure. An additional benefit of this procedure is the specially adjusted size of the particles, which enables the absorption of active compounds into the intestinal villi
Allergy is a common disease in taiwan and china , especially for the highly industrialized region , people are suffering from allergic reaction to the food and environment , but there is still no real effective natural solution to this syndrome. Pollen season is not common in chinese cities , but industrial pollution and food are the main cause of allergic reaction happen to people .
Probiotic natural relief is also popular in taiwanese market , unfortunatelly , the probiotic relief is not a quick relief to allergy , it generally takes over a month or longer to relief the syndrome after taken the pill , thus the market is niched if a quick response solution like lectranal can be introduced to the market. Wedar as a ingredient supplier and formulator is also strong in combination of different ingredients including specific probiotic strains to create novel product to enter the market.
Wedar nutrasouce Inc. A leading branded name nutraceutical ingredient supplier to the asia pacific and chinese market , has already signed a exclusive agreement with a nutraceutical innovator in croatia , named Milsing , to introduce the novel patented allergy relief branded ingredient LECTRANAL , to both china and taiwan market.
Lectranal® is a new allergy relief ingredient.
Lectranal® provides an innovative solution for relieving the following allergic reactions:
- allergic rhinitis
- allergic conjunctivitis
- allergic asthma
- atopic dermatitis
Lectranal® is composed of a herbal and a mineral compound produced by using a patent-pending procedure. For hundreds of years, Astragalus membranaceus, a perennial plant, has been used in traditional Chinese medicine for the relief of indigestion, as well as to strengthen the immune system.
Our scientists target compounds in the roots of Astragalus membranaceus that help relieve allergic reactions. Since we believe that these substances cannot be absorbed in their active form when taken orally, we have developed a new herbal and mineral complex that will enable their oral absorption.
A combination of that specific extract and a mineral carrier is obtained through a patent-pending procedure. An additional benefit of this procedure is the specially adjusted size of the particles, which enables the absorption of active compounds into the intestinal villi
Allergy is a common disease in taiwan and china , especially for the highly industrialized region , people are suffering from allergic reaction to the food and environment , but there is still no real effective natural solution to this syndrome. Pollen season is not common in chinese cities , but industrial pollution and food are the main cause of allergic reaction happen to people .
Probiotic natural relief is also popular in taiwanese market , unfortunatelly , the probiotic relief is not a quick relief to allergy , it generally takes over a month or longer to relief the syndrome after taken the pill , thus the market is niched if a quick response solution like lectranal can be introduced to the market. Wedar as a ingredient supplier and formulator is also strong in combination of different ingredients including specific probiotic strains to create novel product to enter the market.
Sunday, July 08, 2007
查看文章→【Wedar introduce Sinetrol to chinese market】
查看文章→【Wedar introduce Sinetrol to chinese market】
French supplier NB Consulting has developed a new fruit and vegetable-derived ingredients that tap into fierce trends in the nutraceuticals market: Sinetrol, a fat burner derived from citrus , grapefruit and guarana extract .
Wedar Biotechnology , a international branded nutraceutical supplier located in Taiwan and China , already partner with NBConsulting , to introduce Sinetrol to the booming chinese market .
As the economic growth of china is fast , the over weight problem is becomming a health problem , related chronic disease like diabetic and cardiovascular disease is becoming a national health isuue.
Wedar start the sinetrol program in the 2007 CPHI , Shanghai , and will introduce to Taiwan market in the coming event of Taiwan Biotech Fair , July 26-29 2007.
Managing Director of NB Consulting Dr Constantin Dallas , says that Sinetrol has been tested for its lipolytic in human adipocytes in a ex vivo clinical trial at the BioAlternatives laboratory, by measuring the release of free fatty acids.
Sinetrol is a patented synergistic extract made from red orange, orange, grapefruit and guarana extract with total fruit biophenols of 60-80 per cent, flavanones 10-20 per cent HPLC, and caffeine 1-4 per cent.
Human adipocytes from 35-years-old women were collected and treated on the same day with either Sinetrol, a placebo, or 12 percent guarana.
The Sinetrol was seen to increase lipolysis (release of free fatty acid) by 600 per cent more than the placebo, and 200 per cent more than the guarana alone. The effect is attributed to the ingredient inhibiting cathecol-methyl transferase and phosphodiestrerase.
In southern European countries such as France, Spain and Italy, fat burners and weight maintenance products take up a good deal of space on pharmacy shelves.
Wedar will promote the sinetrol brand and product to both china and taiwan market .
French supplier NB Consulting has developed a new fruit and vegetable-derived ingredients that tap into fierce trends in the nutraceuticals market: Sinetrol, a fat burner derived from citrus , grapefruit and guarana extract .
Wedar Biotechnology , a international branded nutraceutical supplier located in Taiwan and China , already partner with NBConsulting , to introduce Sinetrol to the booming chinese market .
As the economic growth of china is fast , the over weight problem is becomming a health problem , related chronic disease like diabetic and cardiovascular disease is becoming a national health isuue.
Wedar start the sinetrol program in the 2007 CPHI , Shanghai , and will introduce to Taiwan market in the coming event of Taiwan Biotech Fair , July 26-29 2007.
Managing Director of NB Consulting Dr Constantin Dallas , says that Sinetrol has been tested for its lipolytic in human adipocytes in a ex vivo clinical trial at the BioAlternatives laboratory, by measuring the release of free fatty acids.
Sinetrol is a patented synergistic extract made from red orange, orange, grapefruit and guarana extract with total fruit biophenols of 60-80 per cent, flavanones 10-20 per cent HPLC, and caffeine 1-4 per cent.
Human adipocytes from 35-years-old women were collected and treated on the same day with either Sinetrol, a placebo, or 12 percent guarana.
The Sinetrol was seen to increase lipolysis (release of free fatty acid) by 600 per cent more than the placebo, and 200 per cent more than the guarana alone. The effect is attributed to the ingredient inhibiting cathecol-methyl transferase and phosphodiestrerase.
In southern European countries such as France, Spain and Italy, fat burners and weight maintenance products take up a good deal of space on pharmacy shelves.
Wedar will promote the sinetrol brand and product to both china and taiwan market .
Subscribe to:
Posts (Atom)